Cargando…

Optimal COVID-19 therapeutic candidate discovery using the CANDO platform

The worldwide outbreak of SARS-CoV-2 in early 2020 caused numerous deaths and unprecedented measures to control its spread. We employed our Computational Analysis of Novel Drug Opportunities (CANDO) multiscale therapeutic discovery, repurposing, and design platform to identify small molecule inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mangione, William, Falls, Zackary, Samudrala, Ram
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452636/ https://www.ncbi.nlm.nih.gov/pubmed/36091793 http://dx.doi.org/10.3389/fphar.2022.970494

Ejemplares similares

Exploration of interaction scoring criteria in the CANDO platform
por: Falls, Zackary, et al.
Publicado: (2019)

Identifying Protein Features Responsible for Improved Drug Repurposing Accuracies Using the CANDO Platform: Implications for Drug Design
por: Mangione, William, et al.
Publicado: (2019)

Effective holistic characterization of small molecule effects using heterogeneous biological networks
por: Mangione, William, et al.
Publicado: (2023)

Combating Ebola with Repurposed Therapeutics Using the CANDO Platform
por: Chopra, Gaurav, et al.
Publicado: (2016)

Multiscale Virtual Screening Optimization for Shotgun Drug Repurposing Using the CANDO Platform
por: Hudson, Matthew L., et al.
Publicado: (2021)

A Deep-Learning Proteomic-Scale Approach for Drug Design
por: Overhoff, Brennan, et al.
Publicado: (2021)

Fingerprinting CANDO: Increased Accuracy with Structure- and Ligand-Based Shotgun Drug Repurposing
por: Schuler, James, et al.
Publicado: (2019)

Shotgun drug repurposing biotechnology to tackle epidemics and pandemics
por: Mangione, William, et al.
Publicado: (2020)

Shotgun drug repurposing biotechnology to tackle epidemics and pandemics
por: Mangione, William, et al.
Publicado: (2020)

352 Computational methods for predicting drug combinations for targeting KRAS mutations relevant to non-small cell lung cancer
por: Bruggemann, Liana, et al.
Publicado: (2022)

Identifying Protein Features and Pathways Responsible for Toxicity Using Machine Learning and Tox21: Implications for Predictive Toxicology
por: Moukheiber, Lama, et al.
Publicado: (2022)

Evaluating the performance of drug-repurposing technologies
por: Schuler, James, et al.
Publicado: (2022)

Accurate Prediction of Inhibitor Binding to HIV-1 Protease Using CANDOCK
por: Falls, Zackary, et al.
Publicado: (2022)

Multiscale Analysis and Validation of Effective Drug Combinations Targeting Driver KRAS Mutations in Non-Small Cell Lung Cancer
por: Bruggemann, Liana, et al.
Publicado: (2023)

Proteomic Network Analysis of Bronchoalveolar Lavage Fluid in Ex-Smokers to Discover Implicated Protein Targets and Novel Drug Treatments for Chronic Obstructive Pulmonary Disease
por: Mammen, Manoj J., et al.
Publicado: (2022)

Association of C>U RNA Editing with Human Disease Variants
por: MANDLOI, Sapan, et al.
Publicado: (2020)

Pathophysiology and Potential Therapeutic Candidates for COVID-19: A Poorly Understood Arena
por: Samaddar, Arghadip, et al.
Publicado: (2020)

A fluorescence-based, gain-of-signal, live cell system to evaluate SARS-CoV-2 main protease inhibition
por: Dey-Rao, Rama, et al.
Publicado: (2021)

The Role of C-to-U RNA Editing in Human Biodiversity
por: Van Norden, Melissa, et al.
Publicado: (2023)

Body composition and chemotherapy toxicity in women with early breast cancer (CANDO-3): protocol for an observational cohort study
por: Durkin, Kesta, et al.
Publicado: (2022)

Discovery of novel immunotherapeutic drug candidates for sciatic nerve injury using bioinformatic analysis and experimental verification
por: Li, Shengyou, et al.
Publicado: (2022)

An Integrated Metabolomic Study of Osteoporosis: Discovery and Quantification of Hyocholic Acids as Candidate Markers
por: Deng, Dawei, et al.
Publicado: (2021)

Nanocurcumin: A Promising Candidate for Therapeutic Applications
por: Karthikeyan, Adhimoolam, et al.
Publicado: (2020)

Using Drosophila melanogaster as a suitable platform for drug discovery from natural products in inflammatory bowel disease
por: Xiu, Minghui, et al.
Publicado: (2022)

A New Therapeutic Candidate for Cardiovascular Diseases: Berberine
por: Cai, Yun, et al.
Publicado: (2021)

Editorial: Therapeutic and Diagnosis Target Discovery Based on Metabolomics
por: Liu, Linsheng
Publicado: (2022)

Current Molecular Therapeutic Agents and Drug Candidates for Mycobacterium abscessus
por: Quang, Nguyen Thanh, et al.
Publicado: (2021)

An updated review on potential therapeutic drug candidates, vaccines and an insight on patents filed for COVID-19
por: Rao, G.S.N. Koteswara, et al.
Publicado: (2021)

Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery
por: Imbrici, Paola, et al.
Publicado: (2016)

Editorial: Platelets in Disease: From Biomarkers Discovery to Therapeutic Targets
por: Zhao, Fan, et al.
Publicado: (2022)

Editorial: Antimycobacterial drug discovery: Molecular therapeutics and target identification
por: Gunosewoyo, Hendra, et al.
Publicado: (2022)

Editorial: Novel therapeutic target and drug discovery for neurological diseases
por: Zhao, Kaiyue, et al.
Publicado: (2022)

Aripiprazole as a Candidate Treatment of COVID-19 Identified Through Genomic Analysis
por: Crespo-Facorro, Benedicto, et al.
Publicado: (2021)

Accelerating Therapeutics for Opportunities in Medicine: A Paradigm Shift in Drug Discovery
por: Hinkson, Izumi V., et al.
Publicado: (2020)

Discovery of Potent Disheveled/Dvl Inhibitors Using Virtual Screening Optimized With NMR-Based Docking Performance Index
por: Hori, Kiminori, et al.
Publicado: (2018)

From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases
por: Cassano, Tommaso, et al.
Publicado: (2020)

Discovery of the key active compounds in Citri Reticulatae Pericarpium (Citrus reticulata “Chachi”) and their therapeutic potential for the treatment of COVID-19 based on comparative metabolomics and network pharmacology
por: Wang, Fu, et al.
Publicado: (2022)

Use of Tox21 Screening Data to Evaluate the COVID-19 Drug Candidates for Their Potential Toxic Effects and Related Pathways
por: Sakamuru, Srilatha, et al.
Publicado: (2022)

Computational Studies of Hydroxychloroquine and Chloroquine Metabolites as Possible Candidates for Coronavirus (COVID-19) Treatment
por: Vaidya, Niteen A., et al.
Publicado: (2020)

The mechanism of action of a novel neuroprotective low molecular weight dextran sulphate: New platform therapy for neurodegenerative diseases like Amyotrophic Lateral Sclerosis
por: Logan, Ann, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mh5dg259sppcunpbsve0cuu6i3